Groups
|
Total proteins
|
ALT
|
AST
|
---|
Concentration (mg/mL)
|
% change
|
Activity (UI/L)
|
% change
|
Activity (UI/L)
|
% change
|
---|
UIC
|
0.91 ± 0.03
| |
116.33 ± 14.28
| |
113.59 ± 9.29
| |
IC
|
0.79 ± 0.02*
|
- 13.19
|
842.60 ± 91.12***
|
+ 624.32
|
267.81 ± 16.34***
|
+ 135.77
|
PZQ
|
0.77 ± 0.03*
|
/
|
171.64 ± 15.69###
|
- 79.63
|
179.78 ± 10.58**, ###
|
- 32.87
|
SpAE 200
|
0.90 ± 0.03#, £
|
+ 13.92
|
159.29 ± 16.13###
|
- 81.09
|
136.76 ± 9.78###, £
|
- 48.93
|
- UIC Uninfected-untreated mice, IC Infected-untreated mice, PZQ Infected mice treated with praziquantel, SpAE 200 Infected mice treated with Sida pilosa aqueous extract at 200 mg/kg
- Data are expressed as mean ± SEM (n = 6). ANOVA followed by Newman-Keuls multiple comparison test was used for statistical analysis. *p < 0.05, **p < 0.01, ***p < 0.001: values are significantly different from those of uninfected-untreated mice (group UIC). #p < 0.05, ###p < 0.001: values are significantly different from those of infected-untreated mice (group IC). £p < 0.05: values are significantly different from those of infected mice treated with praziquantel (group PZQ)